VIMAB Group AB (publ) OMXSTO:VIMAB:
Q3 NET SALES SEK 93 MILLION
Q3 EBIT LOSS SEK 3.7 MILLION VERSUS LOSS SEK 9.9 MILLION YEAR AGO
Vimab Q3 Net Sales SEK 93 Million
Earlier from Vimab Group Ab
- VIMAB: Revenue fell 17.5% in Q2, but major post-period deals are set to boost H2 results
- VIMAB: Revenue and profit declined, but large battery orders and new financing support future prospects
- VIMAB: Major loss in 2024, but large battery orders and divestment set stage for 2025 turnaround